Clinical Trial Update: A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of VSA006 in Chinese patients with nonalcoholic steatohepatitis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• VSA006

Snippet

Sponsor: Visirna Therapeutics HK Limited | Conditions: Nash | Phase 2 | Status: ACTIVE_NOT_RECRUITING